000 01544 a2200457 4500
005 20250515015634.0
264 0 _c20060320
008 200603s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/01.WNL.0000198762.41312.E1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSiemers, E R
245 0 0 _aEffects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease.
_h[electronic resource]
260 _bNeurology
_cFeb 2006
300 _a602-4 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAlanine
_xanalogs & derivatives
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAmyloid Precursor Protein Secretases
650 0 4 _aAspartic Acid Endopeptidases
650 0 4 _aAzepines
_xpharmacokinetics
650 0 4 _aEndopeptidases
_xmetabolism
650 0 4 _aEnzyme Inhibitors
_xpharmacokinetics
650 0 4 _aHumans
650 0 4 _aPlacebos
700 1 _aQuinn, J F
700 1 _aKaye, J
700 1 _aFarlow, M R
700 1 _aPorsteinsson, A
700 1 _aTariot, P
700 1 _aZoulnouni, P
700 1 _aGalvin, J E
700 1 _aHoltzman, D M
700 1 _aKnopman, D S
700 1 _aSatterwhite, J
700 1 _aGonzales, C
700 1 _aDean, R A
700 1 _aMay, P C
773 0 _tNeurology
_gvol. 66
_gno. 4
_gp. 602-4
856 4 0 _uhttps://doi.org/10.1212/01.WNL.0000198762.41312.E1
_zAvailable from publisher's website
999 _c16115923
_d16115923